Intestinal-related Solutions & Services

Intestinal organoids can be a good choice to study the differentiation process of intestinal stem cells, as well as the mechanisms of intestinal tissue regeneration and repair. In addition, they can simulate the absorption, distribution and metabolism of drugs in the Intestinal, helping evaluate the impact of drugs on the Intestinal and the therapeutic effect.

Intestinal Organoids

Intestinal organoids are miniaturized versions of the Intestinal that can be grown in the laboratory and used to study various aspects of intestinal biology and disease. The successful development of an inflammatory bowel disease (IBD) model based on intestinal organoid culture could help researchers better understand the immune response of the intestinal system in IBD and other intestinal diseases.

Intestinal Organoids for Drug Screening

Drug Screening +

Drug Screening

Equipped with the ability to mimic the complex environment and physiological functions of the human Intestinal, intestinal organoids provide a more accurate prediction of drug behavior in the human body.

Intestinal Organoids for Disease Modeling

Intestinal Disease Modeling +

Intestinal Disease Modeling

Intestinal organoids replicate the real intestinal environment, enabling them to mimic the onset and progression of intestinal diseases more accurately.

Intestinal Organoids for Intestinal Absorption Studies

Intestinal Adsorption Studies +

Intestinal Adsorption Studies

Intestinal organoids encompass all types of intestinal epithelial cells and possess physiological functions such as water, ion absorption, and transport. Functions such as intestinal absorption process of nutrients, as well as the transport and metabolism of drugs and bioactive substances can be evaluated.

Intestinal Organoids for Intestinal Development Research

Intestinal Development Research +

Intestinal Development Research

The developmental process of the Intestinal is mimicked through organoids, enabling observation and research on how intestinal cells grow, differentiate, and form complex tissue structures.

Intestinal organoids and differentiation kits are available to support high-throughput differentiation of intestinal organoids from iPSCs.

The cell composition and arrangement of intestinal organoids closely resemble the structure of intestinal epithelium, enabling the maintenance of crypt characteristics even after prolonged culture
The culture cycle of intestinal organoids is relatively short, allowing for freezing and passage of the cultures.
The apical side is located on the outer layer, suitable for absorption tests.

Immunostaining of Intestinal Organoid

The Intestinal Organoids (Cat. No. CIPO-IWL003K) differentiated using the Human iPSC-Derived Intestinal Organoid Differentiation Kit comprise multiple intestinal cell types.

Cat. No. Description
CIPO-IWL003K Ready-to-use Human iPSC-Derived Intestinal Organoids
RIPO-IWM006 Human iPSC-Derived Intestinal Organoid Maintenance Kit

Intestinal Cells

iPSC-differentiated intestinal cells are coming soon!

Interested? Leave a message!

Intestinal Services

Organoid Differentiation and Validation Services

We offer differentiation services to develop Intestinal organoids from iPSCs or human tissue. Organoids are validated by the expression of Intestinal-related protein markers to ensure differentiation and maturity.

Experiments Performed:
Intestinal differentiation
Validation by WB, IF, qPCR for MUC2, Villin and morphological evidence
Deliverables:
Custom Intestinal Organoids
Raw data and images
Detailed validation test report

Drug Screening

We can help measure the ability of intestinal epithelium to absorb nutrients as well as study inflammatory responses and drug-induced enterotoxicity.

Experiments performed:
Cell Toxicity screening test (3D)
Nutrition absorption test (3D)
Immune reaction test (ELISA)
Transepithelial/transendothelial electrical resistance measurement
Deliverables:
Detailed toxicity test report
Raw data and images

Inflammatory Bowel Disease (IBD)

We can help to construct the IBD model and provide corresponding pathological and biochemical evidence. At the same time, we can also provide you with follow-up IBD related drug screening services.

Experiments performed:
IBD model construction on organoids
Validation by WB, IF, qPCR for pathology and immune reaction
Validation of inflammatory factors by ELISA
Deliverables:
Raw data and pictures
Detailed validation test report
Custom IBD model based on organoid

Intestinal Case Studies

Assessment of Drug Toxicity with Intestinal Organoids

Abemaciclib is a CDK4/6 inhibitor commonly used in breast cancer treatment, is frequently associated with clinical side effects such as diarrhea. Treatment of intestinal organoids with abemaciclib can simulate its effects on intestinal epithelial cells.

The integrity of the intestinal barrier depends on the function of tight junction proteins, with transepithelial electrical resistance (TEER) serving as a key indicator for evaluating barrier function—higher TEER values indicate more intact tight junctions and stronger barrier integrity.

Assessment of Drug Toxicity with Intestinal Organoids
Results:
Abemaciclib treatment induced changes in the TEER value of intestinal organoids. Low concentrations initially induced a transient TEER increase, followed by a progressive decline, dropping significantly below baseline by day 5. In contrast, high concentrations led to a sustained decrease in TEER, indicating direct cytotoxic effects.
Immunofluorescence analysis of ZO-1 revealed disruption of tight junctions and morphological damage to epithelial cell (ECAD+), with minimal effects on crypt stem cells (SOX9+). The breakdown of tight junctions likely contributed to TEER reduction, indicating impaired epithelial barrier function, which may result in fluid leakage, pathogen infiltration, and ultimately diarrhea or intestinal inflammation.

LPS-Induced Immune Response in Intestinal Organoids

The intestinal immune system plays a vital role in maintaining gut homeostasis and protecting the host from pathogenic insults. Lipopolysaccharide (LPS), a bacterial toxin, can trigger immune responses in the intestine against pathogens.

Immune Response of Intestinal Organoids
Results:
LPS stimulation induced a dose-dependent increase in cytokines, including IL-6 and CCL2, reflecting an inflammatory response in intestinal organoids.

Related Recommendations

References

1. Li, Vivian SW. "Modelling intestinal inflammation and infection using ‘mini-gut’organoids." Nature reviews Gastroenterology & hepatology 18.2 (2021): 89-90.

2. HOFFMANN P, SCHNEPEL N, LANGEHEINE M, et al. Intestinal organoid-based 2D monolayers mimic physiological and pathophysiological properties of the pig Intestinal[J]. PLoS One, 2021, 16(8): e0256143.

  • Background
  • Intestinal Organoids
  • Intestinal Cells
  • Intestinal Services
  • Intestinal Case Studies
  • Related Recommendations
  • References